COMP and familial pancreatic carcinoma: Additionally, in cancers where disease progression is heavily influenced by the tumor microenvironment, such as pancreatic cancer, COMP deposition in the extracellular matrix might affect the immune system, rendering the tumor more resistant to various therapies.